Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
A conserved annexin A6–mediated membrane repair mechanism in muscle, heart, and nerve
Alexis R. Demonbreun, … , Robert Vassar, Elizabeth M. McNally
Alexis R. Demonbreun, … , Robert Vassar, Elizabeth M. McNally
Published July 22, 2022
Citation Information: JCI Insight. 2022;7(14):e158107. https://doi.org/10.1172/jci.insight.158107.
View: Text | PDF
Research Article Cardiology Muscle biology

A conserved annexin A6–mediated membrane repair mechanism in muscle, heart, and nerve

  • Text
  • PDF
Abstract

Membrane instability and disruption underlie myriad acute and chronic disorders. Anxa6 encodes the membrane-associated protein annexin A6 and was identified as a genetic modifier of muscle repair and muscular dystrophy. To evaluate annexin A6’s role in membrane repair in vivo, we inserted sequences encoding green fluorescent protein (GFP) into the last coding exon of Anxa6. Heterozygous Anxa6gfp mice expressed a normal pattern of annexin A6 with reduced annexin A6GFP mRNA and protein. High-resolution imaging of wounded muscle fibers showed annexin A6GFP rapidly formed a repair cap at the site of injury. Injured cardiomyocytes and neurons also displayed repair caps after wounding, highlighting annexin A6–mediated repair caps as a feature in multiple cell types. Using surface plasmon resonance, we showed recombinant annexin A6 bound phosphatidylserine-containing lipids in a Ca2+- and dose-dependent fashion with appreciable binding at approximately 50 μM Ca2+. Exogenously added recombinant annexin A6 localized to repair caps and improved muscle membrane repair capacity in a dose-dependent fashion without disrupting endogenous annexin A6 localization, indicating annexin A6 promotes repair from both intracellular and extracellular compartments. Thus, annexin A6 orchestrates repair in multiple cell types, and recombinant annexin A6 may be useful in additional chronic disorders beyond skeletal muscle myopathies.

Authors

Alexis R. Demonbreun, Elena Bogdanovic, Lauren A. Vaught, Nina L. Reiser, Katherine S. Fallon, Ashlee M. Long, Claire C. Oosterbaan, Michele Hadhazy, Patrick G.T. Page, Prem Raj B. Joseph, Gabrielle Cowen, Alexander M. Telenson, Ammaarah Khatri, Katherine R. Sadleir, Robert Vassar, Elizabeth M. McNally

×

Figure 3

Genomically encoded annexin A6GFP localizes at the site of cardiomyocyte membrane injury.

Options: View larger image (or click on image) Download as PowerPoint
Genomically encoded annexin A6GFP localizes at the site of cardiomyocyte...
(A) Quantitative PCR demonstrates reduced Anxa6 levels in heart lysates from heterozygous and homozygous Anxa6gfp mice compared with WT controls. (B–D) Anti–annexin A6 immunoblots demonstrate reduced ANXA6 protein levels in cardiac ventricle lysates from heterozygous and homozygous Anxa6gfp mice. The loading control is a 42 kDa band detected by MemCode reversible protein stain. (E) Adult ventricular cardiomyocytes were isolated from homozygous Anxa6gfp mice and subsequently laser-damaged. annexin A6GFP (shown in green) quickly localizes to the cardiomyocyte repair cap (white arrow). (F) Z-projection of a homozygous Anxa6gfp cardiomyocyte illustrating annexin A6GFP repair cap (white arrow) above the annexin-free zone at the site of injury 250 seconds after cardiomyocyte wounding. Scale bar: 5 μm. n = 6 mice per genotype. n > 12 cells from 5 isolations. *P < 0.05 by 1-way ANOVA.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts